to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Small biotechnology firms represent a unique national resource for economic growth that may be the fastest and most efficient mechanism to create technological innovation to convert cutting edge biomedical research into new technology breakthroughs and competitive new products. The NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer(STTR) grant programs provide an opportunity for ALL key players in biomedical research to benefit. SBIR grants provide $850,000 (Phase I and II) or more and STTR grants provide $600,000 (Phase I and II) or more in research dollars to catalyze the commercialization of innovative projects that will benefit public health. Further, these grants offer company scientists an opportunity to pursue innovative projects for which company support may not be available, and they promote and foster partnerships with collaborators, including academic investigators. By serving as a collaborator, consultant, or principal investigator (for STTR), an academic investigator can gain long-term financial and scientific benefits. Collaboration with a company also offers access to company resources and expertise and possibly jobs for graduate students and postdoctoral fellows. In a rapidly changing culture where research institutions are becoming more committed to innovation and entrepreneurship to enhance the economic development of their regions, NIH SBIR and STTR grants can add value to an academic institution’s intellectual property. With rapidly expanding biological knowledge, even large corporations can develop only a limited number of promising lead ideas. Large pharmaceutical corporations often look to small biotechnology companies for the initial development of embryonic technology. Thus, the end of a successful project for a small biotechnology company is often the beginning of R&D for a large pharmaceutical corporation. NIH small business grants can help bridge the needs of both by providing early-stage funding for research that adds value to an idea, promoting partnerships that lead to a marketable product.
NIH Lab to Life Funding Guide
The Small Business Innovation Research (SBIR) program is a set-aside program (2.5% of an agency's extramural budget) for domestic small business concerns to engage in Research/Research and Development (R/R&D) that has the potential for Commercialization.
In partnership with agencies across the federal government, the more than 50 TPP professionals and staff work to maximize the benefits of open markets for global economic development, address and resolve trade disputes, strengthen intellectual property enforcement, and improve access for U.S. goods and services abroad.
We encourage and advocate the use of veteran-owned firms as sourcing resources for our internal and external customers. We promote contracting opportunities for veteran-owned businesses and strongly encourage utilization of these resources to the maximum extend practicable. We have implemented a mentor-protégé program, service disabled veteran-owned small business initiative, and support industry-wide as well as industry specific outreach and training.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.